ELF Stock Analysis: ELF Beauty | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 6.482m USD | 12M Return: 51.7% | US26856L1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 145M
EPS Trend: 19.6%
Qual. Beats: 2
Rev. Trend: 98.1%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 10 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
e.l.f. Beauty, Inc. is a global beauty company that designs and sells cosmetics and skin care products across eye, lip, face, and skin care categories. The company markets its products under multiple brand names, including e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Rhode, reflecting a multi-brand portfolio strategy common within the personal care products industry.
The company distributes its products through two main channels: national and international retailers (wholesale) and direct-to-consumer e-commerce, a hybrid model that allows it to reach both brick-and-mortar shoppers and online customers. This dual-channel approach is typical of mass-market beauty brands seeking broad consumer reach.
Founded in 2004 and headquartered in Oakland, California, the company was originally called J.A. Cosmetics Holdings, Inc. before adopting its current name in April 2016. It trades on the NYSE under the ticker ELF and is classified within the Consumer Staples sector under the Personal Care Products sub-industry.
- Rhode brand acquisition expands skincare and category reach
- International segment revenue grows double digits on new retailer wins
- Gross margin pressure persists from tariffs and elevated promotional spending
| Net Income: 86.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 4.62 > 1.0 |
| NWC/Revenue: 30.81% < 20% (prev 32.14%; Δ -1.33% < -1%) |
| CFO/TA 0.11 > 3% & CFO 288.2m > Net Income 86.6m |
| Net Debt (659.3m) to EBITDA (309.1m): 2.13 < 3 |
| Current Ratio: 2.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.1m) vs 12m ago 0.83% < -2% |
| Gross Margin: 74.42% > 18% (prev 70.27%; Δ 4.15% > 0.5%) |
| Asset Turnover: 79.37% > 50% (prev 59.76%; Δ 19.61% > 0%) |
| Interest Coverage Ratio: 4.91 > 6 (EBIT TTM 229.7m / Interest Expense TTM 46.8m) |
| A: 0.23 (Total Current Assets 977.6m - Total Current Liabilities 380.2m) / Total Assets 2.57b |
| B: -0.02 (Retained Earnings -59.3m / Total Assets 2.57b) |
| C: 0.09 (EBIT TTM 229.7m / Avg Total Assets 2.44b) |
| D: 0.91 (Book Value of Equity 1.23b / Total Liabilities 1.34b) |
| Altman-Z'' = 3.04 = A |
| DSRI: 1.14 (Receivables 246.2m/154.7m, Revenue 1.94b/1.39b) |
| GMI: 0.94 (GM 70.27% / 74.42%) |
| AQI: 0.89 (AQ_t 0.60 / AQ_t-1 0.68) |
| SGI: 1.40 (Revenue 1.94b / 1.39b) |
| TATA: -0.08 (NI 86.6m - CFO 288.2m) / TA 2.57b) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of November 08, 2026, the stock is trading at USD 116.14 with a total of 2,270,255 shares traded. Over the past week, the price has changed by +3.98%, over one month by +12.99%, over three months by +25.82% and over the past year by +51.74%.
Current recommended Stop Loss: 106.00 (which is 8.7% or 2 ATR below the current price).
ELF Beauty has received a consensus analysts rating of 4.28. Therefore, it is recommended to buy ELF.
- StrongBuy: 11
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 117.1 | 0.9% |
P/E Trailing = 77.3592
P/E Forward = 37.7358
P/S = 3.343
P/B = 5.2953
P/EG = 1.3707
Revenue TTM = 1.94b USD
EBIT TTM = 229.7m USD
EBITDA TTM = 309.1m USD
Long Term Debt = 809.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 1.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 97.3m
Net Debt = 659.3m USD (calculated: Debt 1.01b - CCE 350.8m)
Enterprise Value = 7.14b USD (6.48b + Debt 1.01b - CCE 350.8m)
Interest Coverage Ratio = 4.91 (Ebit TTM 229.7m / Interest Expense TTM 46.8m)
EV/FCF = 25.90x (Enterprise Value 7.14b / FCF TTM 275.7m)
FCF Yield = 3.86% (FCF TTM 275.7m / Enterprise Value 7.14b)
FCF Margin = 14.22% (FCF TTM 275.7m / Revenue TTM 1.94b)
Net Margin = 4.47% (Net Income TTM 86.6m / Revenue TTM 1.94b)
Gross Margin = 74.42% ((Revenue TTM 1.94b - Cost of Revenue TTM 496.0m) / Revenue TTM)
Gross Margin QoQ = 71.09% (prev 83.20%)
Tobins Q-Ratio = 2.78 (Enterprise Value 7.14b / Total Assets 2.57b)
Interest Expense / Debt = 4.63% (Interest Expense 46.8m / Debt 1.01b)
Taxrate = 13.81% (18.0m / 130.6m)
NOPAT = 198.0m (EBIT 229.7m * (1 - 13.81%))
Current Ratio = 2.57 (Total Current Assets 977.6m / Total Current Liabilities 380.2m)
Debt / Equity = 0.82 (Debt 1.01b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = 2.13 (Net Debt 659.3m / EBITDA 309.1m)
Debt / FCF = 2.39 (Net Debt 659.3m / FCF TTM 275.7m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 86.6m / Total Assets 2.57b)
RoE = 7.39% (Net Income TTM 86.6m / Total Stockholder Equity 1.17b)
RoCE = 11.60% (EBIT 229.7m / Capital Employed (Equity 1.17b + L.T.Debt 809.3m))
RoIC = 9.34% (NOPAT 198.0m / Invested Capital 2.12b)
WACC = 9.97% (E(6.48b)/V(7.49b) * Re(10.90%) + D(1.01b)/V(7.49b) * Rd(4.63%) * (1-Tc(0.14)))
Discount Rate = 10.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 77.04 | Cagr: 1.16%
[DCF] Terminal Value 72.92% ; FCFF base≈222.2m ; Y1≈254.7m ; Y5≈374.9m
[DCF] Fair Price = 63.18 (EV 4.39b - Net Debt 659.3m = Equity 3.73b / Shares 59.0m; r=9.97% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 19.58 | EPS CAGR: 1.98% | SUE: 1.22 | # QB: 2
Revenue Correlation: 98.07 | Revenue CAGR: 27.46% | SUE: 2.32 | # QB: 4
EPS current Quarter (2026-12-31): EPS=0.86 | Chg30d=+1.61% | Revisions=+25% | Analysts=18
EPS current Year (2027-03-31): EPS=3.66 | Chg30d=+0.99% | Revisions=+75% | GrowthEPS=+16.8% | GrowthRev=+21.0%
EPS next Year (2028-03-31): EPS=3.96 | Chg30d=+2.69% | Revisions=+58% | GrowthEPS=+8.2% | GrowthRev=+8.9%
[Analyst] Revisions Ratio: +63% (up=23, down=4)